Drugs - Real World Outcomes

PCSK9 inhibitors usage in South China: A Multi-Center Real-World Study

By Qiuyan Yu, Tiantian Ma, Fengmei Huang, Celine Sze Ling Chui

Study in peopleInterventions

The paper

Qiuyan Yu, Tiantian Ma, Fengmei Huang, Celine Sze Ling Chui

University of Hong Kong; University of Hong Kong - Shenzhen Hospital

Drugs - Real World Outcomes, 6 Oct 2026

doi.org/10.1007/s40801-026-00586-2 PubMed 42837057

Journal of Diabetes and Metabolic Disorders4 Oct 2026
Cumulative non-HDL cholesterol is linked to CVD risk
American Journal of Preventive Cardiology4 Oct 2026
Most US adults meeting PREVENT risk thresholds lack lipid therapy